There was a problem adding this course to your account. Please try again in a few minutes. If the problem persists, you can contact our support department at (877) 880-1335.
Adding Registration, Please wait...
You must be logged in to perform this action.
Log in
Cancel
COVID-19: The Impact on Litigation in the Pharmaceutical Industry and Mitigating Risk with Litigation Finance
Credit(s):
1.2 50-Minute Credit Hour (General)
1 60-Minute Credit Hour (General)
1 Australia (General)
1 CA (General Participatory)
1 IL (General)
1 NY (Transitional)
1 PA (Substantive-Distance Learning)
1 TX (General)
1 UK (General)
This program features a discussion on how COVID-19 has impacted the of pharmaceutical and medical product supply chains. Presenters discuss technology trends on pharmaceutical operations, nature of potential disputes, force majeure, and other key topics.
Pharma industry disputes and impact of operations
Litigation effect on federal operations -- future disputes likely to result from related business disruption
Impact on federal court and other agencies, including FDA and USPTO
Applying litigation finance to pharma and life sciences